Factor V Leiden mutation and contraception

Gynecological Endocrinology

Volumn 10, Issue SUPPL. 2, 1996, Pages 85-87

  Helmerhorst, F M ^a   Bloemenkamp, K W M ^a   Briet E ^a   Van Der Meer, F J M ^a   Rosendaal, F R ^a   Vandenbroucke, J P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Factor V Leiden mutation; Oral contraceptives; Venous Thromboembolism

Indexed keywords

EID: 0002020711     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609045635     Document Type: Article

References (10)

1. Koster, T., Small, R.A., Rosendaal, F.R. and Helmerhorst, F.M. (1995). Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties. J. Int. Med., 238, 31-7
2. Farmer, R.D.T. and Preston, T.D. (1995). The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J. Obstet. Gynecol., 15, 195-200
3. Vandenbroucke, J.P., Koster, T., Briët, E., Reitsma, P.H., Bertina, R.M. and Rosendaal, F.R. (1994). Increased risk of venous thrombosis in oral-contraceptive users who are carriers of Factor V Leiden mutation. Lancet, 334, 1453-7
4. Vademecum of Health Statistics of The Netherlands (1994). Netherlands Central Bureau of Statistics. Ministry of Welfare, Health and Cultural Affairs. Voorburg 1994.
5. Stadel, B.V. (1981). Oral contraceptives and cardiovascular disease. N. Engl. J. Med., 305, 612-18; 672-7
6. Anderson, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W., Patwardhan, A., Jovanovic, B., Forrier, A. and Dalen, J.E. (1991). A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch. Intern. Med., 151, 933-8
7. Pasi, K.J., Perry, D.J. and Lee, C.A. (1995). Thromboembolism and the combined oral contraceptive pill. Lancet, 345, 1437
8. Rees, C.R., Cox, M. and Clegg, J.B. (1995). World distribution of factor V Leiden. Lancet, 346, 1133-4
9. Sackett, D.L., Haynes, R.B., Guyatt, G.H. and Tagwell, P. (eds.) (1991). Early diagnosis. In Clinical Epidemiology, 2nd edition (Boston, Toronto, London: Little Brown and Company)
10. Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. and Reitsma, P.H. (1995). High risk of thrombosis in patients homozygous for factor V Leiden (Activated Protein C Resistance). Blood, 85, 1504-8